• My Dashboard My Education Find an Ophthalmologist
  • Home
  • Coronavirus
  • For Ophthalmologists
    • Meetings
      • AAO 2022
        • Meeting Information
          • Past and Future Meetings
          • Mobile Meeting Guide
          • Contact Information
          • Annual Meeting News
          • Health and Safety
          • Policies and Disclaimers
        • Program
          • Program Highlights
          • Subspecialty Day
          • Virtual Meeting
          • Program Committees
          • CME
          • Meeting Archives
        • Expo
        • Registration
        • Hotels & Travel
          • Hotel Reservation Information
          • Chicago
          • International Attendees
          • Hotel Meeting Space
        • Presenter Central
          • Presenter Central
          • Abstract Selection Process
          • Submission Policies
          • Subject Classification/Topics
          • Instruction Courses and Skills Transfer Labs
          • Papers and Posters
          • Videos
          • Grand Rounds Symposium
          • Program Participant and Faculty Guidelines
          • Faculty Development Program
        • Exhibitors
          • Exhibitor Central
          • Exhibitor Portal Information
          • Exhibitor Prospectus
          • New Exhibiting Companies
          • Exhibitor Resources
          • International Exhibitors
          • Promotional Opportunities
          • Exhibitor Hotel Reservations
      • Mid-Year Forum
        • Registration and Travel
        • Congressional Advocacy Day
        • Advocacy Ambassador Program
        • Program
        • Schedule
        • Sponsored Attendees
        • News
      • Codequest
        • Codequest Instructors
        • Claim Codequest CME or CEU Credit
      • Eyecelerator
    • Clinical Education
      • COVID-19
      • Education
        • Browse All Education
        • Courses
        • Cases
        • Learning Plans
        • Interactive
        • Focal Points
        • Wills Eye Manual
        • Disease Reviews
        • Clinical Webinars
        • Diagnose This
        • Self-Assessments
        • Educational Centers
          • Glaucoma Education Center
          • Pediatric Ophthalmology Education Center
          • Laser Surgery Education Center
          • Myopia Resources
          • Oculofacial Plastic Surgery Center
          • Redmond Ethics Center
      • Journals
      • Guidelines
        • Browse All Practice Guidelines
        • Preferred Practice Patterns
        • Clinical Statements
        • Compendium Guidelines
        • Complementary Therapy Assessments
        • Medical Information Technology
        • Ophthalmic Technology Assessments
        • Patient Safety Statements
        • Choosing Wisely
        • Low Vision
        • Eye Care for Older Adults
        • Eye Disease Statistics
        • About the Hoskins Center
      • Video and Image Library
        • Browse All Videos
        • Clinical and Surgical Videos
        • Presentations and Lectures
        • 1-Minute Videos
        • Master Class Videos
        • Basic Skills Videos
        • Interviews
        • Images
        • Submit an Image
        • Submit a Video
      • Podcasts
        • Browse All Audio and Podcasts
        • Experts InSight
        • Ophthalmology Journal
      • News
        • Browse All Clinical News
        • Editors' Choice
        • Headlines
        • Current Insight
      • CME Central
        • Browse All CME Activities
        • Claim CME Credit and View Transcript
        • CME Planning Resources
        • Complete Your Financial Disclosure
        • Joint Sponsorship Portal
        • LEO Continuing Education Recognition Award
        • Safe ER/LA Opioid Prescribing
        • Check Your Industry Payment Records
      • MOC
      • Resident Education
        • Resident Education Home
        • Browse All Resident Content
          • Courses
          • Flashcards
          • Interactive Cases and Simulations
          • Videos
          • Webinars
        • OKAP and Board Exam Resources
          • OKAP Exam
          • Board Prep Resources
          • OKAP and Board Review Presentations
          • Study Flashcards
        • Cataract Master
        • Diversity and Inclusion Education
        • News and Advice from YO Info
        • Pediatric Ophthalmology Education Center
        • PGY-1 and PGY-2 Resources
        • Simulation in Resident Education
    • Membership
      • Join
      • Renew
      • Current Member
      • Volunteer
      • Physician Wellness
      • Member Directory
      • Member Obituaries
      • AAOE Membership
    • Advocacy
      • Advocacy News
      • Get Involved
        • Ways to Give
        • How to Get Involved
        • Congressional Advocacy
        • Support the Academy's Agenda
        • Research Legislation
        • Find Your Legislators
        • I Am an Advocate
        • Advocacy at Home
        • Advocate Tools
        • Best Practices for Advocating at Home
        • Social Media Toolkit
        • Letter to Editor
        • Town Hall Guide
        • Guide to Engaging With New Lawmakers
        • Resources
        • Attending a Political Fundraiser
      • OPHTHPAC
        • About Us
        • Join OPHTHPAC
        • OPHTHPAC Blog
      • Surgical Scope Fund
        • Support Surgery By Surgeons
        • Surgery By Surgeons Blog
    • Publications
      • EyeNet Magazine
        • Latest Issue
        • Archive
        • Subscribe
        • Advertise
        • Write For Us
        • Corporate Lunches
        • Contact
        • MIPS 2022
      • Focal Points
      • Ophthalmology
      • Ophthalmology Glaucoma
      • Ophthalmology Retina
      • YO Info
      • Scope
    • Subspecialties
      • Cataract/Anterior Segment
      • Comprehensive Ophthalmology
      • Cornea/External Disease
      • Glaucoma
      • Neuro-Ophthalmology/Orbit
      • Ocular Pathology/Oncology
      • Oculoplastics/Orbit
      • Pediatric Ophthalmology/Strabismus
      • Refractive Management/Intervention
      • Retina/Vitreous
      • Uveitis
    • IRIS Registry
      • About
      • Using the Registry
        • User Guide
        • Medicare Reporting
        • Maintenance of Certification
        • Non-EHR Reporting
      • Sign Up
        • Application Process
        • Why Participate
        • Once You've Applied: Getting Started
        • What Practices Are Saying About the Registry
      • Requirements
        • EHR Systems
        • Data & Technical Needs
      • Research
      • Registry Dashboard
      • News
      • Medicare & MIPS
    • Medicare Information
    • Diversity, Equity, and Inclusion
  • For Practice Management
    • Managing Your Practice
      • Managing Your Practice Topics
      • Coronavirus Resources
      • Reopening & Recovery
      • Practice Forms Library
      • Practice Management News and Advice
      • AAOE-Talk
      • Video Library
      • Ophthalmology Job Center
      • Benchmarking and Salary Tools
      • Academy Consultations
      • Consultant Directory
    • Coding
      • Coding Topics
      • Codequest Events
      • Ask the Coding Experts
      • Coding Updates and Resources
      • Coding for Injectable Drugs
      • EM Documentation
      • ICD-10-CM
      • Ophthalmic Coding Specialist (OCS) Exam
      • Retina
      • Savvy Coder
    • Webinars and Events
      • Annual Meeting
      • Codequest Courses
      • Mid-Year Forum
      • Webinar Recordings
    • IRIS Registry
      • Merit-Based Incentive Payment
    • Medicare and MIPS
      • MIPS
        • Quality
        • Promoting Interoperability
        • Improvement Activities
        • Cost
        • Avoid a Penalty
      • Resources
      • Medicare Participation Options
      • Medicare Advantage Plans
      • New Medicare Card
      • Provider Enrollment, Chain and Ownership System (PECOS)
    • Regulatory Compliance
      • HIPPA Resources
      • Office of Inspector General
      • Audits
      • OSHA
    • AAOE Membership
      • Join AAOE
      • Membership Benefits
      • Renew/Pay Dues
    • About AAOE
      • AAOE Board of Directors
      • AAOE Content Committee
      • Volunteer Opportunities
  • For Public & Patients
    • Eye Health A-Z
    • Symptoms
    • Glasses & Contacts
    • Tips & Prevention
    • News
    • Ask an Ophthalmologist
    • Patient Stories
    • No Cost Eye Exams
    • Español
      • A - Z de Salud Ocular
      • Síntomas
      • Anteojos y Lentes de Contacto
      • Consejos y Prevención
      • Noticias
      • Relatos de Pacientes
      • Exámenes de la vista sin costo
      • English
  • AAO 2022
    • Meeting Information
      • Past and Future Meetings
      • Mobile Meeting Guide
      • Contact Information
      • Annual Meeting News
      • Health and Safety
      • Policies and Disclaimers
    • Program
      • Program Highlights
      • Subspecialty Day
      • Virtual Meeting
      • Program Committees
      • CME
      • Meeting Archives
    • Expo
    • Registration
    • Hotels & Travel
      • Hotel Reservation Information
      • Chicago
      • International Attendees
      • Hotel Meeting Space
    • Presenter Central
      • Presenter Central
      • Abstract Selection Process
      • Submission Policies
      • Subject Classification/Topics
      • Instruction Courses and Skills Transfer Labs
      • Papers and Posters
      • Videos
      • Grand Rounds Symposium
      • Program Participant and Faculty Guidelines
      • Faculty Development Program
    • Exhibitors
      • Exhibitor Central
      • Exhibitor Portal Information
      • Exhibitor Prospectus
      • New Exhibiting Companies
      • Exhibitor Resources
      • International Exhibitors
      • Promotional Opportunities
      • Exhibitor Hotel Reservations
  • About
    • Who We Are
      • What We Do
      • About Ophthalmology
      • The Eye Care Team
      • Ethics and the Academy
      • History
      • Museum of Vision
      • Values
    • Governance
      • Council
      • Board of Trustees
      • Committees
      • Academy Past Presidents
      • Secretariats
      • Elections
      • Academy Blog
      • Academy Staff Leadership
    • Leadership Development
    • Awards
      • Laureate Recognition Award
      • Outstanding Advocate Award
      • Outstanding Humanitarian Service Award
      • International Blindness Prevention Award
      • Distinguished Service Award
      • Guests of Honor
      • Secretariat Award
      • Straatsma Award
      • Achievement Award Program
      • Artemis Award
      • EnergEYES Award
      • International Education Award
      • International Scholar Award
      • Commitment to Advocacy Award
      • Visionary Society Award
    • Financial Relationships
    • Policy Statements
    • Related Organizations
      • Subspecialty/Specialized Interest Society Directory
      • State Society Directory
      • Subspecialty/Specialized Interest Society Meetings
      • State Society Meetings
      • Resources for Societies
    • Year in Review
      • 2020 Year in Review
  • Foundation
    • About
      • 2020-2021 Annual Report
      • Annual Report Archives
      • News From the Chair
      • Foundation Staff
    • Our Impact
      • Partners for Sight
      • Donor Spotlights
      • Global Ophthalmic Community
      • Sponsorships
      • Patients and the Public
    • Giving Options
      • Our Supporters
      • Estate and Planned Giving
      • Ophthalmic Business Council
      • Parke Center Campaign
      • Minority Ophthalmology Mentoring Campaign
      • Museum of the Eye Campaign
    • Orbital Gala
      • Why Attend
      • Photo Recap
      • Corporate Support Opportunities
      • Tribute Gifts
      • Silent Auction
      • Corporate Sponsors
    • Donate
    • Museum of the Eye Campaign
      • Museum Supporters
  • Museum of the Eye
    • Visit
    • What's On
      • Museum Galleries
      • Special Exhibitions
      • Current Events
      • Past Events
    • Explore
      • Research and Resources
      • Collection Search
      • Previous Exhibits
      • Oral Histories
      • Biographies
    • Volunteer
    • Mailing List
    • Donate
    • About the Museum
      • Museum Blog
  • Young Ophthalmologists
    • YO Info
    • Learn to Bill
    • Engage with the Academy
  • Senior Ophthalmologists
    • Scope
    • Practice Transitions
  • International Ophthalmologists
    • Global Programs and Resources for National Societies
    • Awards
    • Global Outreach
  • Residents
  • Medical Students
×
Shop
Log In Create an Account
  • For Ophthalmologists
  • For Practice Management
  • For Public & Patients
  • Coronavirus
  • About
  • Foundation
  • Museum of the Eye
  • COVID-19
  • Journals
  • Education
    • Education
    • Courses
    • Cases
    • Learning Plans
    • Interactive
    • Focal Points
    • Wills Eye Manual
    • Disease Reviews
    • Clinical Webinars
    • Diagnose This
    • Self-Assessments
    • Education Centers
      • Glaucoma Education Center
      • Pediatric Ophthalmology Education Center
      • Laser Surgery Education Center
      • Oculofacial Plastic Surgery Center
      • Redmond Ethics Center
      • Myopia Resources
      • Thyroid Eye Disease Resources
  • Guidelines
    • Practice Guidelines
    • Preferred Practice Patterns
    • Clinical Statements
    • Ophthalmic Technology Assessments
    • Patient Safety Statements
    • Complementary Therapy Assessments
    • Compendium Guidelines
    • Medical Information Technology
    • Low Vision
    • Choosing Wisely
    • Eye Care for Older Adults
    • Eye Disease Statistics
    • About the Hoskins Center
    • Artificial Intelligence
    • Premium IOLs
    • Patient-Reported Outcomes with LASIK Symptoms and Satisfaction
  • Multimedia
    • Multimedia Library
    • Video
      • 1-Minute Videos
      • Presentations and Lectures
      • Master Class Videos
      • Basic Skills Videos
      • Clinical and Surgical Videos
      • Interviews
      • Resident Lectures
      • Submit a Video
      • YO Video Contest
    • Podcasts
      • Browse Podcast Archive
      • Experts InSight Podcast
      • Ophthalmology Journal Podcast
    • Images
      • Submit an Image
  • News
    • Clinical News
    • Editors' Choice
    • Headlines
    • Current Insight
  • CME
    • CME Central
    • Claim CME Credit and View Transcript
    • CME Planning Resources
    • Complete Your Financial Disclosure
    • Joint Sponsorship Portal
    • LEO Continuing Education Recognition Award
    • Safe ER/LA Opioid Prescribing
    • Check Your Industry Payment Records
  • MOC
  • Residents
    • Resident Education Home
    • Browse All Resident Content
      • Courses
      • Flashcards and Study Presentations
      • Interactive Cases and Simulations
      • Videos
      • Webinars
    • Cataract Master
    • Diversity and Inclusion Education
    • News and Advice from YO Info
    • OKAP and Board Exam Resources
      • OKAP Exam
      • Board Prep Resources
      • OKAP and Board Review Presentations
      • Study Flashcards
    • Pediatric Ophthalmology Education Center
    • PGY-1 and PGY-2 Resources
    • Resident Knowledge Exchange
    • Simulation in Resident Education
    • Clinical Education /
    • Book Excerpts /
    • Basic and Clinical Science Course - Excerpt
  • 2020–2021 BCSC Basic and Clinical Science Course™

    Go to Academy Store Learn more and Purchase.

    8 External Disease and Cornea

    Chapter 8: Systemic Disorders With Corneal and Other Anterior Segment Manifestations

    Inherited Metabolic Diseases

    Disorders of Amino Acid, Nucleic Acid, Protein, and Mineral Metabolism

    Cystinosis

    Cystinosis is a rare autosomal recessive metabolic disorder, affecting 3.5 infants per 1 million births. The disease is characterized by the accumulation of the amino acid cystine within lysosomes. The defective gene in cystinosis, CTNS, has been mapped to 17p13. See also BCSC Section 6, Pediatric Ophthalmology and Strabismus.

    PATHOGENESIS

    A defect in transport across the lysosomal membrane leads to intracellular accumulation of cystine.

    CLINICAL PRESENTATION

    Cystinosis is categorized on the basis of the patient’s age at diagnosis and the severity of symptoms. Nephropathic cystinosis is divided into infantile (classic) and intermediate (juvenile or adolescent) forms. Dwarfism and progressive renal dysfunction are prominent in infantile cystinosis and less severe in the juvenile disease. Life expectancy is normal in nonnephropathic cystinosis (formerly called adult cystinosis). All 3 types are characterized by the deposition of fine iridescent and polychromatic cystine crystals in the conjunctiva, cornea, iris, and other parts of the eye. The crystals are densest in the peripheral cornea but are present throughout the anterior stroma, even within the central cornea (Fig 8-4), and can be seen in the trabecular meshwork with gonioscopy. Patients with cystinosis often have photophobia, and the crystals can recur following PK. Table 8-2 lists other causes of corneal crystals; Table 8-3 summarizes the ocular and systemic findings in disorders of amino acid metabolism.

    Figure 8-4 Nonnephropathic cystinosis. Slit-lamp photograph showing diffuse stromal refractile crystals.

    (Courtesy of Stephen E. Orlin, MD.)

    Liang H, Baudouin C, Tahiri JHR, Brignole-Baudouin F, Labbe A. Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior segment optical coherence tomography study. Invest Ophthalmol Vis Sci. 2015;56(5): 3218–3225.

    LABORATORY EVALUATION

    Cystine crystals may be seen in conjunctiva, blood leukocytes, or bone marrow.

    MANAGEMENT

    Topical cysteamine 0.44% is a commercially available agent used to reduce the density of the crystals and diminish corneal pain, possibly by reducing the frequency of corneal erosions. Cysteamine is thought to react with intracellular cystine, forming a cysteine–cysteamine disulfide that resembles lysine and is transported through the lysosome by the normal lysine transport system. Posterior segment manifestations such as pigmentary retinopathy and optic nerve involvement may be treated with oral cysteamine, which may also prevent or delay other manifestations of the disease, including death.

    Table 8-2 Differential Diagnosis of Corneal Crystals

    Table 8-3 Disorders of Amino Acid Metabolism

    Tyrosinemia

    Tyrosinemia encompasses a group of inborn errors in the metabolism of the amino acid tyrosine. Tyrosinemia type I, caused by fumarylacetoacetate deficiency, is not associated with corneal pathology. Tyrosinemia type II (Richner-Hanhart syndrome) is characterized by hyperkeratotic lesions of the palms, soles, and elbows, as well as eventual cognitive impairment; corneal manifestations of this syndrome are discussed under Clinical Presentation.

    PATHOGENESIS

    Tyrosinemia type II is an autosomal recessive disorder resulting from defective tyrosine aminotransferase, which leads to excess tyrosine in the blood and urine. The elevated tyrosine level likely has a direct effect on lysosomal membranes, leading to enzyme release. The gene defect is located at 16q22.1–22.3.

    CLINICAL PRESENTATION

    Ocular changes include marked photophobia, tearing, conjunctival injection, and tarsal papillary hypertrophy. Affected patients experience recurrent episodes of corneal erosions and pseudodendrites (Fig 8-5), which usually do not stain well with fluorescein or rose bengal. Continued episodes of epithelial breakdown can result in corneal vascularization and scarring. It is important to consider this disorder in young children who may carry a diagnosis of recurrent herpes simplex virus keratitis.

    LABORATORY EVALUATION

    Hypertyrosinemia and tyrosinuria with normal phenylalanine levels and conjunctival biopsy showing soluble tyrosine aminotransferase deficiency are diagnostic.

    Figure 8-5 Slit-lamp photograph showing a pseudodendrite in a patient with tyrosinemia.

    (Courtesy of Robert W. Weisenthal, MD.)

    MANAGEMENT

    Restriction of dietary intake of tyrosine and phenylalanine can reduce the severity of both the corneal and systemic changes, including cognitive impairment. The institution of appropriate dietary restrictions, even later in life, can improve mental status.

    Alkaptonuria

    Alkaptonuria is a rare autosomal recessive disorder caused by deficiency of the enzyme homogentisic acid oxidase, which leads to an accumulation of homogentisic acid. The defect is caused by mutations in the HGD gene, which maps to 3q13.33. The frequency of alkaptonuria is unusually high in the Dominican Republic and Slovakia.

    PATHOGENESIS

    Homogentisate 1,2-dioxygenase, the enzyme necessary to degrade tyrosine and phenylalanine, is deficient in patients with this disorder. Phenylalanine and tyrosine cannot be metabolized beyond homogentisic acid, which is oxidized and polymerized into alkapton, a brown-black material similar to melanin. Alkapton binds to collagen and is then deposited in connective tissues as a dark pigment; this process is known as ochronosis.

    CLINICAL PRESENTATION

    Systemic findings include arthropathy; renal calculi; and pigmentation of cartilaginous structures, including earlobes, trachea, nose, tendons, dura mater, heart valves, and prostate. Eventually, medial and lateral rectus muscle tendons and the sclera adjacent to the tendon insertions develop a smudgelike bluish-black pigmentation (Fig 8-6). Darkly pigmented, dotlike opacities, similar to those seen in spheroidal degeneration, may appear in the corneal epithelium or in the Bowman layer, near the limbus.

    LABORATORY EVALUATION

    The urine of affected patients turns dark on standing. Alkaptonuria is diagnosed by finding elevated levels of homogentisic acid in the urine.

    Figure 8-6 Slit-lamp photograph from a female patient with alkaptonuria, showing ochronosis (scleral pigmentation) at the insertion of the lateral rectus muscle.

    (Courtesy of Irving M. Raber, MD.)

    MANAGEMENT

    No specific therapy is available, but high-dose ascorbic acid may reduce arthropathy in young patients. Gene therapy may be a future treatment.

    Srinivasan S, Shehadeh-Mashor R, Slomovic AR. Corneal manifestations of metabolic diseases. In: Mannis MJ, Holland EJ, eds. Cornea. Vol 1. 4th ed. Philadelphia: Elsevier; 2017:620–644.

    Amyloidosis

    The amyloidoses are a heterogeneous group of diseases characterized by the extracellular accumulation of amyloid in various tissues and organs, including the cornea and conjunctiva. Amyloid deposits may be composed of many different types of proteins, including immunoglobulin fragments. The deposits are insoluble and inert, but they interfere with the normal structure and function of tissues and organs.

    Amyloid has the following staining characteristics:

    • positive staining with Congo red dye

    • dichroism and birefringence

    • metachromasia with crystal violet dye

    • fluorescence in ultraviolet light with thioflavin T stain

    • typical filamentous appearance on electron microscopy

    CLASSIFICATION AND CLINICAL PRESENTATION

    Ocular amyloidosis is classified as either primary (idiopathic) or secondary (to a chronic disease) and as either localized or systemic. A useful classification of amyloidosis considers these 4 types. Each type is summarized in Table 8-4.

    Primary localized amyloidosis is the most common form of ocular amyloidosis. Conjunctival amyloid plaques occur in the absence of systemic involvement (Fig 8-7). Gelatinous droplike corneal dystrophy (formerly primary familial amyloidosis), classic lattice corneal dystrophy (LCD1), and lattice variants are special forms of primary localized amyloidosis and are discussed in Chapter 7. Polymorphic amyloid degeneration is discussed in Chapter 6.

    Table 8-4 Amyloid in the Eye

    Figure 8-7 Clinical photograph of the inferior palpebral conjunctiva, showing moderate thickening with yellowish amyloid deposition.

    (Courtesy of Stephen E. Orlin, MD.)

    Primary systemic amyloidosis is a heterogeneous group of diseases in which waxy, ecchymotic eyelid papules occur in association with vitreous veils and opacities as well as with pupillary anomalies such as light–near dissociation. Orbital involvement, extraocular muscle involvement with ophthalmoplegia, and scleral infiltration with uveal effusion have been reported. The most common form of primary systemic amyloidosis is an autosomal dominant group of diseases linked to mutations in the transthyretin gene (TTR, prealbumin) on chromosome 18 (18q11.2–q12.1); more than 40 mutations in this gene have been described.

    Familial amyloidosis, Finnish type, or gelsolin type (Meretoja syndrome) is an example of primary systemic amyloidosis. This condition was initially described in persons of Finnish descent but was later reported in individuals of other ethnicities. Previously called lattice corneal dystrophy type 2, it has been excluded as a corneal dystrophy by the International Committee for the Classification of Corneal Dystrophies (IC3D) because of its systemic associations.

    Familial amyloidosis presents in the third to fourth decade of life. Because the ocular symptoms are the first to arise, the ophthalmologist is often the first physician to see patients with this condition, who typically present with corneal findings. Affected patients have a characteristic facial mask; dermatochalasis; lagophthalmos; pendulous ears; cranial and peripheral nerve palsies; and dry, lax skin with amyloid deposition (Fig 8-8). The classic corneal lattice lines are less numerous and more peripheral, and they spread centripetally from the limbus. The central cornea is relatively spared; corneal sensation is reduced. The risk of open-angle glaucoma may be increased, and dry eye and recurrent erosions may occur late in life.

    PATHOLOGY OF FAMILIAL AMYLOIDOSIS

    Light microscopy shows amyloid in the lattice lines as a discontinuous band under the Bowman layer and within the sclera. The amyloid in this condition is related to gelsolin and does not stain for type AA or AP. The mutated gelsolin is observed to be deposited in the conjunctiva, sclera, and ciliary body; along the choriocapillaris; in the ciliary nerves and vessels; and in the optic nerve. Extraocularly, amyloid is detected in arterial walls, peripheral nerves, and glomeruli. On confocal microscopy, deposits are observed along the basal epithelial cells and stromal nerves.

    Figure 8-8 A, Diffuse lattice lines in Meretoja syndrome. B, Typical facies.

    (Reproduced with permission from Weiss JS, Møller H, Lisch W, et al. The ICD3 classification of the corneal dystrophies. Cornea. 2008; 27(10 Suppl 2):S16.)

    Reidy JJ. Corneal and conjunctival degenerations. In: Mannis MJ, Holland EJ, eds. Cornea. Vol 1. 4th ed. Philadelphia: Elsevier; 2017:856–874.

    Srinivasan S, Shehadeh-Mashor R, Slomovic AR. Corneal manifestations of metabolic diseases. In: Mannis MJ, Holland EJ, eds. Cornea. Vol 1. 4th ed. Philadelphia: Elsevier; 2017: 620–644.

    Gout

    Disorders of purine metabolism cause hyperuricemia (increased uric acid). Gout results from deposition of urate crystals in the joints or kidney.

    PATHOGENESIS

    Hyperuricemia may be familial, arising from an enzyme deficiency (eg, hypoxanthine phosphoribosyltransferase in Lesch-Nyhan syndrome). More commonly, gout is polygenic or secondary to obesity, cytotoxic chemotherapy, myeloproliferative disease, diuretic therapy, or excessive alcohol consumption.

    CLINICAL PRESENTATION

    Acute inflammation of the sclera, episclera, or conjunctiva can occur. Fine corneal epithelial and stromal deposits may appear in the absence of inflammation. Either an orange-brown band keratopathy or a typical whitish band keratopathy is seen in rare cases.

    LABORATORY EVALUATION

    Serum uric acid level is typically elevated. However, in urate keratopathy, the uric acid level may be normal in the presence of keratopathy if there is no concurrent inflammation.

    MANAGEMENT

    Indomethacin, colchicine, or phenylbutazone is used for acute treatment; long-term reduction in uric acid levels should be pursued with medications such as allopurinol. Superficial corneal deposits can be removed mechanically with scraping or keratectomy.

    Wilson disease

    PATHOGENESIS

    Wilson disease (hepatolenticular degeneration) is an autosomal recessive disorder caused by multiple allelic substitutions or deletions in a Cu2+-ATPase-transporting β-polypeptide, linked to mutations in the ATP7B gene on chromosome 13 (13q14.3–q21). Copper is deposited first in the liver, then in the kidneys, and eventually in the brain and the cornea at the Descemet membrane (Fig 8-9).

    CLINICAL PRESENTATION

    Muscular rigidity increases, and tremor and involuntary movement gradually occur in a fluctuating course resembling parkinsonism. Unintelligible speech and mild dementia usually occur concomitantly. Equal numbers of patients (40%) present with hepatic or nervous system symptoms. In the cornea, a golden-brown, ruby-red, or green pigment ring (Kayser-Fleischer ring) consisting of copper deposits appears in peripheral Descemet membrane (see Fig 8-9), although not all patients with Wilson disease manifest this ring. Copper deposition occurs in the posterior Descemet membrane, first superiorly, then gradually spreading to meet inferior deposits. Gonioscopy may assist in visualizing the ring. A “sunflower” cataract may be present.

    The differential diagnosis includes primary biliary cirrhosis, chronic active hepatitis, exogenous chalcosis, and progressive intrahepatic cholestasis of childhood. These and other non-Wilsonian hepatic disorders can also be associated with Kayser-Fleischer rings, but only Wilson disease is characterized by decreased serum ceruloplasmin levels and neurologic symptoms.

    LABORATORY EVALUATION

    Patients with Wilson disease can be differentiated from patients with other diseases that show Kayser-Fleischer rings by their inability to incorporate radioactive copper into ceruloplasmin. Low serum ceruloplasmin, high non-ceruloplasmin-bound serum copper, and high urinary copper suggest the diagnosis, which can be confirmed with liver biopsy. Nonspecific findings of proteinuria, aminoaciduria, glycosuria, uricaciduria, hyperphosphaturia, and hypercalciuria are seen.

    MANAGEMENT

    Wilson disease can be treated with penicillamine. Liver transplantation is reserved for patients with fulminant liver failure. The Kayser-Fleischer ring disappears gradually with therapy, including liver transplant, and the disappearance of the rings can be used to help monitor therapy. Electrophysiologic abnormalities from retinal dysfunction have been shown to reverse after treatment of the disease.

    Figure 8-9 Wilson hepatolenticular degeneration. Deposits of copper in the Descemet membrane (Kayser-Fleischer ring).

    (Reproduced with permission from Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. 3rd ed. Vol 1. Philadelphia: Elsevier/Mosby; 2011:299.)

    Porphyria

    The porphyrias are a group of disorders characterized by excess production and excretion of porphyrins, which are pigments involved in the synthesis of heme.

    PATHOGENESIS

    Porphyria cutanea tarda, the form most commonly associated with ocular surface disease, is either sporadic or inherited in an autosomal dominant pattern (band 1p34). The enzyme uroporphyrinogen decarboxylase is deficient, resulting in an accumulation of porphyrins in the liver and in the circulation. Typically, a second insult to the liver, such as alcoholism or drug metabolism, triggers the condition in late middle age.

    A severe form of porphyria, called hepatoerythropoietic porphyria (HEP), is a homozygous presentation of the same enzymatic defect, but onset of the disease is in infancy.

    CLINICAL PRESENTATION

    Hyperpigmentation, erythema, scleroderma-like changes, increased fragility, and vesicular and ulcerative lesions occur on sun-exposed surfaces of the body. There is interpalpebral injection, and the conjunctiva may develop vesicles, scarring, and symblepharon mimicking bullous pemphigoid; conjunctival necrosis may also occur. Necrotizing scleritis has been reported. The cornea may be affected by exposure or by thinning and perforation at the limbus. Skin and ocular lesions may fluoresce.

    LABORATORY EVALUATION

    Urine turns dark on standing. Reduced liver and red cell uroporphyrinogen decarboxylase activity confirms the diagnosis. Hepatic biopsy shows liver parenchymal cells filled with porphyrins that fluoresce bright red in ultraviolet light.

    MANAGEMENT

    Protection from ultraviolet light and reduction of iron by phlebotomy or subcutaneous deferoxamine are the principal treatments. No specific ocular treatment is available, although artificial tears may help wash away porphyrins. Corneal thinning and perforation are treated in standard ways.

    Srinivasan S, Shehadeh-Mashor R, Slomovic AR. Corneal manifestations of metabolic diseases. In: Mannis MJ, Holland EJ, eds. Cornea. Vol 1. 4th ed. Philadelphia: Elsevier; 2017:620–644.

    Excerpted from BCSC 2020-2021 series: Section 10 - Glaucoma. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.

  • Most Commented
    Loading, please wait...
    There are no comments available.
    Most Viewed
    Loading, please wait...
    Most Viewed content is not available.
  • The Academy Store
    The Technician Point System: How to Improve Practice Accountability and Bottom Line (Free Member Webinar)
    Transitioning Your Practice: Retiring, Selling or Buying a Practice (Free Member Webinar)
    How to Build a Patient-First Culture (Free Member Webinar)
    2022 IRIS Registry (Intelligent Research in Sight) Preparation Kit
    Advances in Medical and Surgical Management: The 2022 Update on Glaucoma
    Presbyopia-Correcting IOLs
    2022 Codequest - Multistate (Recorded March 29)
    2022 Codequest Virtual (Multistate)
    Retina Patient Education Video Collection
    Cataract and Refractive Surgery Patient Education Video Collection
    Glaucoma Patient Education Video Collection
    Oculoplastics Patient Education Video Collection
    Pediatrics Patient Education Video Collection
    2022 Coding Coach: Complete Ophthalmic Coding Reference 
    2022 CPT: Complete Pocket Ophthalmic Reference
    2022 Retina Coding: Complete Reference Guide
    2022 Fundamentals of Ophthalmic Coding
    2022 CPT Professional Edition 
    2022 HCPCS Level ll Professional Edition
    2022 Coding Assistant for Subspecialties 
    2022 Coding Assistant: Cataract and Anterior Segment
    2022 Coding Assistant: Cornea
    2022 Coding Assistant: Glaucoma
    2022 Coding Assistant: Oculofacial
    2022 Coding Assistant: Pediatrics/Strabismus
    2022 ICD-10-CM for Ophthalmology: The Complete Reference 
    Practical Ophthalmology: Manual for Beginning Residents, 8th Edition
    Practical Ophthalmology: Manual for Beginning Residents, 8th Edition eBook
    Practical Ophthalmology: Manual for Beginning Residents, 8th Edition Print + eBook
    Practical Ophthalmology, 8th Edition
 
  • Contact Us
  • About the Academy
  • Jobs at the Academy
  • Financial Relationships with Industry
  • Medical Disclaimer
  • Privacy Policy
  • Terms of Service
  • Help
  • For Advertisers
  • For Media
  • Ophthalmology Job Center

OUR SITES

  • EyeWiki
  • International Society of Refractive Surgery

FOLLOW THE ACADEMY

Medical Professionals

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Public & Patients

  • Facebook
  • Twitter
  • Instagram
  • YouTube

Museum of the Eye

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Trip Advisor
  • Yelp
© American Academy of Ophthalmology 2022